Melissa Tosca
Director of Finance/CFO chez KIORA PHARMACEUTICALS, INC.
Fortune : 24 639 $ au 31/03/2024
Profil
Melissa Tosca is currently working as the EVP-Finance, Chief Financial & Accounting Officer at Kiora Pharmaceuticals, Inc. She also holds the position of Executive Vice President-Finance at the same company.
Previously, she worked at Neomorph, Inc. as the Treasurer & Executive Director-Finance.
Ms. Tosca completed her undergraduate degree at the University of Arizona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 34 900 ( 0,13% ) | 24 639 $ | 31/03/2024 |
Postes actifs de Melissa Tosca
| Sociétés | Poste | Début |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Anciens postes connus de Melissa Tosca
| Sociétés | Poste | Fin |
|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Director of Finance/CFO | - |
Formation de Melissa Tosca
| University of Arizona | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
